SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-12-421118
Filing Date
2012-10-11
Accepted
2012-10-11 17:15:17
Documents
7
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-Q d401713d10qa.htm 10-Q/A 37547
  Complete submission text file 0001193125-12-421118.txt   3166285

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT kalop-20120630.xml EX-101.INS 546928
3 XBRL TAXONOMY EXTENSION SCHEMA kalop-20120630.xsd EX-101.SCH 37930
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kalop-20120630_cal.xml EX-101.CAL 44959
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kalop-20120630_def.xml EX-101.DEF 108087
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE kalop-20120630_lab.xml EX-101.LAB 257947
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kalop-20120630_pre.xml EX-101.PRE 190685
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54735 | Film No.: 121140485
SIC: 2834 Pharmaceutical Preparations